Daily Stock Analysis, BAX, Baxter International Inc, priceseries

Baxter International Inc. Daily Stock Analysis
Stock Information
Open
49.32
Close
49.73
High
49.74
Low
49.30
Previous Close
49.42
Daily Price Gain
0.31
YTD High
49.74
YTD High Date
Feb 17, 2017
YTD Low
44.06
YTD Low Date
Jan 3, 2017
YTD Price Change
5.29
YTD Gain
11.90%
52 Week High
50.01
52 Week High Date
Oct 25, 2016
52 Week Low
37.26
52 Week Low Date
Feb 23, 2016
52 Week Price Change
11.76
52 Week Gain
30.98%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jul 28. 2015
37.42
Aug 12. 2015
39.87
11 Trading Days
6.53%
Link
LONG
Oct 15. 2015
33.21
Nov 12. 2015
37.00
20 Trading Days
11.42%
Link
LONG
Apr 12. 2016
41.67
May 17. 2016
44.55
25 Trading Days
6.93%
Link
Company Information
Stock Symbol
BAX
Exchange
NYSE
Company URL
http://www.baxter.com
Company Phone
8479482000
CEO
José E. Almeida
Headquarters
Illinois
Business Address
ONE BAXTER PKWY, DF2-1W, DEERFIELD, IL 60015
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0000010456
About

Baxter International Inc. provides a portfolio of renal and hospital products. Its Renal segment provides products and services to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies.

Description

Baxter International Inc. provides a portfolio of renal and hospital products. Its Renal segment provides products and services to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis (HD), home HD, continuous renal replacement therapy, and additional dialysis services. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. Baxter International Inc. offers its products through direct sales force, independent distributors or sales agents, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. The company was founded in 1931 and is headquartered in Deerfield, Illinois.